Nuvation Bio Inc. (NUVB) Misses Q4 EPS by 2c

Nuvation Bio Inc. (NYSE: NUVB) reported Q4 EPS of ($0.11), $0.02 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $41.9 million versus the consensus estimate of $38.55 million.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral
• Fed policy stance keeps Treasury yields high, says Citadel Securities